Parkinson’s boost in €10bn EU funding round

Europe

Author: George TheohariPublished: 29 July 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

EU announces investment in new treatments for Parkinson’s

Parkinson’s will be one of the main health areas to benefit from funding under the European Investment Bank’s (EIB) latest investment round.

The EIB – the EU’s long-term lending institution – has approved €10 billion of loans for a variety of strategic projects around the world.

These include medical research into Parkinson’s and epilepsy, as well as a host of infrastructure projects and investment in corporate research in the energy, automobile, and textile sectors.

Details of the investment in Parkinson’s have yet to be announced, but previously the EIB has provided funds for the development of new treatments by the Portuguese pharmaceutical company Bial.

In 2010-13 the EIB committed €50 million in loans to Bial’s research and development activities on drugs for epilepsy, cardiovascular affections and Parkinson’s disease.

Go Back

Share this story

Comments


Related articles


Author Nick Pernisco

Perspectives

Guest writer Nick Pernisco on his “warrior mentality”

A guest post from author Nick Pernisco

READ MORE

Global update

Indian Ocean Row 2018: the story so far

An update on the four men rowing 3,600 miles for Parkinson’s

READ MORE
2 year old with PD lead

Perspectives

Two-year-old could be world’s youngest person diagnosed with Parkinson’s

Toddler diagnosed with juvenile Parkinson’s disease with dystonia

READ MORE